EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson)

Saccharomyces cerevisiae
Evidence Level
Limited
0 Clinical Trials
3 Documented Benefits
2/5 Evidence Score

EatLess® is a yeast (Saccharomyces cerevisiae) hydrolysate peptide complex from Anderson Global Group, developed to support appetite control and satiety for weight management. It is backed by several manufacturer-conducted human studies; independent published data are limited.

Studied Dose Commonly around 250 to 1,000 mg per day.
Active Compound Yeast (Saccharomyces cerevisiae) hydrolysate peptide complex.

Benefits

Appetite control

EatLess is positioned to support satiety and reduce appetite, helping with the calorie control that underlies weight management.

Weight-management support

In manufacturer-conducted human studies, the peptide complex supported appetite and weight-management measures; independent published data are limited.

Limited-evidence note

Support comes mainly from supplier-sponsored trials, so expectations should be realistic.

Mechanism of action

1

Satiety-hormone signaling

The yeast peptides are studied for influencing satiety hormones such as CCK and GLP-1, which signal fullness to the brain.

2

Appetite regulation

By enhancing fullness signaling, the complex is positioned to reduce food intake between meals.

Clinical trials

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED.
Mild digestive upset is occasionally reported.
Pair with a balanced diet for best results.

Important Drug interactions

No major drug interactions are established for this ingredient.
Tell your doctor about all supplements if you take prescription medication.
Use caution if pregnant, breastfeeding, or managing a health condition.

Frequently asked questions about EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson)

What is EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson)?

EatLess® is a yeast (Saccharomyces cerevisiae) hydrolysate peptide complex from Anderson Global Group, developed to support appetite control and satiety for weight management. It is backed by several manufacturer-conducted human studies; independent published data are limited.

What is the recommended dosage of EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson)?

The clinically studied dose for EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson) is Commonly around 250 to 1,000 mg per day.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson) used for?

EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson) is studied for appetite control, weight-management support, limited-evidence note. EatLess is positioned to support satiety and reduce appetite, helping with the calorie control that underlies weight management.

Are there side effects from taking EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED. Mild digestive upset is occasionally reported. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson) safe to take?

Whether EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED. It may also interact with certain medications. EatLess® (Yeast-Hydrolysate Satiety Peptide — Anderson) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.